News
20 February 2026
From Quality to Public Trust
In the healthcare industry, public trust is not built overnight. It grows through consistent quality assurance, adherence to standards, and contributions that are tangibly felt by society. As demands for transparency continue to rise, healthcare companies are expected not only to deliver good products, but also to establish accurate and…
3 February 2026
Dexa Medica Receives the 2026 BPOM Achievement Award as Indonesia’s Leading Phytopharmaceutical Company
Dexa Medica has once again affirmed its role as a pioneer in Indonesia’s pharmaceutical industry through an award presented by the National Agency of Drug and Food Control (BPOM) of the Republic of Indonesia. The BPOM Achievement Award 2026 in the category of Pioneer with the Highest Number of Phytopharmaceutical…
30 January 2026
Dexa Group’s Consistent Reputation Management Wins the 8th Indonesia Public Relations Awards
Winning the award for eight consecutive times, Dexa Group demonstrates long-term consistency in building public trust. This commitment has once again led Dexa Group to receive the Indonesia Public Relations Awards (IPRA) 2026 with the title of Best Public Relations 2026 in Public Trust Building through Ethical Pharmaceutical Practices. This…
17 December 2021
CEO Dexa Group Achieved Most Acclaimed CEO Award 2021
For the ability to adapt and continue to innovate to maintain the continuity of the company's business activities, CEO Dexa Group Mr. Ferry Soetikno received the "Indonesia Most Acclaimed CEO Award 2021" with Outstanding Leadership in Expanding Corporate Business Segmentation in the pharmaceutical category from WartaEkonomi.co.id. The Most Acclaimed CEO…
15 December 2021
Dexa Group Donates Medicines through BNPB for Semeru Eruption Victims
The national pharmaceutical company Dexa Group participated in donating a number of medicines through the National Disaster Management Agency (BNPB) to treat the health of residents affected by the eruption of Mount Semeru in Lumajang, East Java. According to BPNP data on December 6, 2021, residents affected by the eruption…
8 December 2021
Dexa Group Appreciated by Government for Contribution to Improving National Industry Competitiveness through OMAI Research and Innovation
Taking an active role in increasing the competitiveness of the national industry through research and sustainable technological innovation in the pharmaceutical sector, Dexa Laboratories of Biomolecular Sciences (DLBS) received the Rintisan Teknologi Industri 2021 award from the Ministry of Industry of the Republic of Indonesia. The award was handed over…
22 October 2021
Dexa Medica Wins Primaniyarta Award 2021 for OMAI Stimuno’s Marketing Achievements Abroad
PT Dexa Medica won the Primaniyarta 2021 award for the New Market Pioneer category. The Primaniyarta 2021 winners' awards were announced at the opening ceremony of the Trade Expo Indonesia Digital Edition (TEI DE), on Thursday, October 21, 2021. The President of the Republic of Indonesia, Mr. Joko Widodo (Jokowi)…
13 October 2021
HerbaASIMOR Wins Indonesia Digital Marketing Champion 2021 Award
Dexa Medica through HerbaASIMOR won the Indonesia Digital Marketing Champion 2021 award as the 1st Digital Marketing Champion 2021 in the Healthcare Products category with the title Very Good. This award was achieved for Dexa Medica's achievements in improving business performance through digital platforms. The award was given by SWA's…
1 September 2021
Dexa Group Ramps Up Business in SE Asia by Launching Glorious Dexa Singapore Pte. Ltd.
Dexa Group, the leading pharmaceutical company from Indonesia, is ramping up its business in Southeast Asia with the launch of Glorious Dexa Singapore, Pte. Ltd. (GDS) based in Singapore. Dexa Group has exported medicines to various countries starting with Myanmar since 1993 and began exporting international standard medicines to Singapore…
23 August 2021
Government Appreciates Industry 4.0 Implementation by Dexa Group
The Ministry of Industry continues to improve the competitiveness of the national industry through the transformation towards industry 4.0. In this regard, as a leading international pharmaceutical company in Indonesia, Dexa Group has implemented Industry 4.0 in the production process to distribution. President Director of PT Ferron Par Pharmaceuticals, Mr.…